Venus Concept (VERO) Stock Price, News & Analysis

Company Overview

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $0.31 to $0.32
• 50-Day Range: $0.31 to $0.47
• 52-Week Range: $0.28 to $2.22
• Volume: 30,311 shs
• Average Volume: 126,576 shs
• Market Capitalization: $2.25 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VERO Stock Analysis - Frequently Asked Questions

How have VERO shares performed this year?

Venus Concept's stock was trading at $0.3765 at the beginning of 2025. Since then, VERO stock has decreased by 17.6% and is now trading at $0.3101.
View the best growth stocks for 2025 here.

How were Venus Concept's earnings last quarter?

Venus Concept Inc. (NASDAQ:VERO) posted its quarterly earnings results on Monday, March, 27th. The company reported ($2.10) earnings per share for the quarter, meeting analysts' consensus estimates of ($2.10). The business earned $24.29 million during the quarter.

When did Venus Concept's stock split?

Shares of Venus Concept reverse split before market open on Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

How do I buy shares of Venus Concept?

Shares of VERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Venus Concept own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Venus Concept investors own include Tesla (TSLA), Agenus (AGEN), Cisco Systems (CSCO), Taiwan Semiconductor Manufacturing (TSM), Intel (INTC), Pfizer (PFE) and

Company Calendar

• Last Earnings: 3/27/2023
• Today: 2/22/2025
• Next Earnings (Estimated): 3/31/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:VERO
• CUSIP: N/A
• CIK: 1409269
• Web: www.venusconcept.com
• Phone: (888) 907-0115
• Fax: N/A
• Employees: 410
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($8.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-37,250,000.00
• Net Margins: -74.62%
• Pretax Margin: -74.60%
• Return on Equity: N/A
• Return on Assets: -47.46%

Debt

• Debt-to-Equity Ratio: 2.83
• Current Ratio: 1.86
• Quick Ratio: 1.18

Sales & Book Value

• Annual Sales: $76.35 million
• Price / Sales: 0.03
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.43) per share
• Price / Book: -0.13

Miscellaneous

• Outstanding Shares: 7,260,000
• Free Float: 3,703,000
• Market Cap: $2.25 million
• Optionable: Not Optionable
• Beta: 0.51